101.87
price up icon2.16%   2.15
after-market Dopo l'orario di chiusura: 101.95 0.08 +0.08%
loading
Precedente Chiudi:
$99.72
Aprire:
$99.3
Volume 24 ore:
1.17M
Relative Volume:
1.18
Capitalizzazione di mercato:
$24.42B
Reddito:
$3.30B
Utile/perdita netta:
$-501.07M
Rapporto P/E:
8.8288
EPS:
11.5384
Flusso di cassa netto:
$1.03B
1 W Prestazione:
-6.31%
1M Prestazione:
-8.86%
6M Prestazione:
+12.43%
1 anno Prestazione:
+2.50%
Intervallo 1D:
Value
$98.25
$102.48
Intervallo di 1 settimana:
Value
$94.31
$115.93
Portata 52W:
Value
$76.53
$131.49

Biontech Se Adr Stock (BNTX) Company Profile

Name
Nome
Biontech Se Adr
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
6,133
Name
Cinguettio
@BioNTech_Group
Name
Prossima data di guadagno
2024-11-04
Name
Ultimi documenti SEC
Name
BNTX's Discussions on Twitter

Confronta BNTX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
BNTX 101.87 24.42B 3.30B -501.07M 1.03B 11.54
VRTX 467.01 119.87B 10.63B -479.80M -1.35B 13.33
REGN 762.00 83.27B 13.85B 4.65B 3.32B 35.06
ARGX 567.90 33.96B 1.86B -40.29M -1.28B -4.16
ALNY 232.27 30.18B 2.09B -332.26M 16.06M -4.14

Biontech Se Adr Stock (BNTX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-09-24 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2024-09-17 Aggiornamento Jefferies Hold → Buy
2024-09-16 Aggiornamento JP Morgan Underweight → Neutral
2024-08-07 Aggiornamento Deutsche Bank Hold → Buy
2024-08-02 Aggiornamento HSBC Securities Hold → Buy
2024-05-14 Iniziato Evercore ISI In-line
2024-02-23 Iniziato BMO Capital Markets Outperform
2024-01-05 Iniziato Oppenheimer Perform
2023-12-01 Downgrade JP Morgan Neutral → Underweight
2023-10-16 Downgrade HSBC Securities Buy → Hold
2023-07-14 Iniziato HSBC Securities Buy
2023-05-17 Aggiornamento Redburn Neutral → Buy
2022-12-15 Aggiornamento BofA Securities Neutral → Buy
2022-08-17 Iniziato Cowen Market Perform
2022-07-13 Aggiornamento SVB Leerink Mkt Perform → Outperform
2022-07-06 Ripresa Canaccord Genuity Buy
2022-02-01 Aggiornamento Redburn Sell → Neutral
2021-12-16 Iniziato Morgan Stanley Equal-Weight
2021-11-10 Aggiornamento H.C. Wainwright Neutral → Buy
2021-10-22 Iniziato Deutsche Bank Hold
2021-10-07 Iniziato Jefferies Hold
2021-08-11 Aggiornamento Bryan Garnier Neutral → Buy
2021-07-19 Ripresa Wolfe Research Outperform
2021-06-16 Downgrade Redburn Neutral → Sell
2021-05-18 Iniziato Goldman Neutral
2021-05-11 Downgrade Bryan Garnier Buy → Neutral
2020-12-01 Downgrade BofA Securities Buy → Neutral
2020-08-03 Ripresa Berenberg Buy
2020-07-21 Aggiornamento BofA Securities Neutral → Buy
2020-06-30 Downgrade H.C. Wainwright Buy → Neutral
2020-05-19 Aggiornamento H.C. Wainwright Neutral → Buy
2020-04-28 Downgrade BofA/Merrill Buy → Neutral
2020-03-18 Downgrade JP Morgan Overweight → Neutral
2020-03-09 Iniziato H.C. Wainwright Neutral
2020-01-24 Downgrade SVB Leerink Outperform → Mkt Perform
2020-01-22 Downgrade UBS Buy → Neutral
2019-11-05 Iniziato Wolfe Research Outperform
2019-11-04 Iniziato Berenberg Buy
2019-11-04 Iniziato BofA/Merrill Buy
2019-11-04 Iniziato Canaccord Genuity Buy
2019-11-04 Iniziato JP Morgan Overweight
2019-11-04 Iniziato SVB Leerink Outperform
2019-11-04 Iniziato UBS Buy
Mostra tutto

Biontech Se Adr Borsa (BNTX) Ultime notizie

pulisher
Nov 16, 2024

BioNTech SE ADR (BNTX): An Important Analyst Insights - Stocks Register

Nov 16, 2024
pulisher
Nov 15, 2024

Powell Speaks The Truth - Benzinga

Nov 15, 2024
pulisher
Nov 15, 2024

Goodwin, Conyers, A&O Shearman Act on $800M China Biotech Sale - Law.com International

Nov 15, 2024
pulisher
Nov 14, 2024

BioNTech ADR Clears Technical Benchmark, Hitting 80-Plus RS Rating - Investor's Business Daily

Nov 14, 2024
pulisher
Nov 13, 2024

BioNTech SE ADR rises Wednesday, outperforms market - MarketWatch

Nov 13, 2024
pulisher
Nov 13, 2024

BioNTech Boosts Oncology Strategy With $800 Million+ China-Based Biotheus Acquisition - Benzinga

Nov 13, 2024
pulisher
Nov 12, 2024

BioNTech SE ADR falls Tuesday, underperforms market - MarketWatch

Nov 12, 2024
pulisher
Nov 11, 2024

BioNTech SE ADR falls Monday, underperforms market - MarketWatch

Nov 11, 2024
pulisher
Nov 08, 2024

BioNTech SE ADR rises Friday, outperforms market - MarketWatch

Nov 08, 2024
pulisher
Nov 06, 2024

BioNTech SE ADR falls Wednesday, underperforms market - MarketWatch

Nov 06, 2024
pulisher
Nov 05, 2024

BioNTech SE ADR rises Tuesday, outperforms market - MarketWatch

Nov 05, 2024
pulisher
Nov 04, 2024

BioNTech SE Reports Strong Q3 2024 Results - TipRanks

Nov 04, 2024
pulisher
Nov 04, 2024

This 6%-yielding U.S. pharma giant is a safe hold - The Globe and Mail

Nov 04, 2024
pulisher
Nov 01, 2024

BioNTech SE ADR falls Friday, underperforms market - MarketWatch

Nov 01, 2024
pulisher
Oct 31, 2024

BioNTech SE ADR outperforms market despite losses on the day - MarketWatch

Oct 31, 2024
pulisher
Oct 28, 2024

Will Non-COVID Drugs Again Boost Pfizer's Top Line in Q3 Earnings? - Nasdaq

Oct 28, 2024
pulisher
Oct 28, 2024

BioNTech to Report Q3 Earnings: Is a Beat in the Cards? - MSN

Oct 28, 2024
pulisher
Oct 24, 2024

BioNTech SE ADR rises Thursday, outperforms market - MarketWatch

Oct 24, 2024
pulisher
Oct 21, 2024

BioNTech's mRNA Technology and Acquired Oncology Programs Could Support a Future Moat - Morningstar

Oct 21, 2024
pulisher
Oct 16, 2024

BioNTech SE ADR rises Wednesday, still underperforms market - MarketWatch

Oct 16, 2024
pulisher
Oct 15, 2024

A better buy-in window may exist right now for BioNTech SE ADR (BNTX) - SETE News

Oct 15, 2024
pulisher
Oct 09, 2024

Insider’s View: Deciphering BioNTech SE ADR (BNTX)’s Financial Health Through Ratios - The Dwinnex

Oct 09, 2024
pulisher
Oct 08, 2024

BioNTech SE ADR (BNTX)’s stock decline to 121.55 per share - US Post News

Oct 08, 2024
pulisher
Oct 07, 2024

BioNTech SE ADR falls Monday, still outperforms market - MarketWatch

Oct 07, 2024
pulisher
Oct 07, 2024

What is BioNTech SE ADR (BNTX) Stock Return on Shareholders’ Capital? - SETE News

Oct 07, 2024
pulisher
Oct 03, 2024

BioNTech SE ADR (BNTX)’s results reveal risk - US Post News

Oct 03, 2024
pulisher
Oct 02, 2024

Gaining Ground: BioNTech SE ADR (BNTX) Closes Higher at 119.93, Up 0.98 - The Dwinnex

Oct 02, 2024
pulisher
Oct 01, 2024

ARCT Stock Up as Updated COVID-19 Jab Betters PFE & BNTX's Comirnaty - Yahoo Finance

Oct 01, 2024
pulisher
Oct 01, 2024

BioNTech unveils AI advancements in immunotherapy - Investing.com

Oct 01, 2024
pulisher
Sep 30, 2024

BioNTech SE ADR rises Monday, outperforms market - MarketWatch

Sep 30, 2024
pulisher
Sep 30, 2024

BioNTech SE ADR (BNTX) can make a big difference with a little luck - SETE News

Sep 30, 2024
pulisher
Sep 27, 2024

Wall Street SWOT: BioNTech stock shows promise amid oncology pipeline growth - Investing.com

Sep 27, 2024
pulisher
Sep 26, 2024

Are Smart Investors Making the Right Decision? BioNTech SE ADR (BNTX) - SETE News

Sep 26, 2024
pulisher
Sep 24, 2024

What Are You Thinking About Investing In BioNTech SE ADR (NASDAQ: BNTX) Stock? - Stocks Register

Sep 24, 2024

Biontech Se Adr Azioni (BNTX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$187.69
price down icon 0.81%
$232.27
price down icon 1.40%
$359.21
price down icon 1.11%
$39.51
price up icon 7.22%
$567.90
price up icon 0.65%
Capitalizzazione:     |  Volume (24 ore):